Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.01 AUD | -0.33% | +0.84% | -6.16% |
Apr. 29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Official Publications